How Medicare Pays for Implanted Devices: Bundles, Claim Lines and the Hospital Margin

Medical device Medicare reimbursement usually pays the hospital or surgery center for the stay or procedure, with the implant’s cost included. The institution buys the product. Medicare pays for the health care. Purchasing may hold an invoice, the operating room an implant record and billing a device line, while the implant still has no separate payment. When reimbursement advice inflates a hospital claim or a qualifying replacement credit stays off it, Medicare and the taxpayers who fund it pay too much.

How Does Reimbursement Work for Medical Devices?

Medicare usually pays for the procedure or hospital stay that includes the implant. The hospital buys the product, and the physician bills separately for the work.

The surgeon may make or strongly influence the choice of implant. HHS-OIG calls these physician preference items. The hospital or surgery center carries the acquisition cost even though the physician helps decide which product it buys.

Under consignment, the manufacturer can retain ownership while the implant sits at the hospital. Use or implantation completes the sale in these arrangements. An item arriving in the stockroom and an item becoming a hospital expense are therefore different events.

Edwards Lifesciences says it recognizes revenue from consigned inventory once the customer has implanted or used the product. It also reviews consignment inventories to check customer reporting. The hospital’s usage report tells the manufacturer a sale has occurred. That gives an insider a concrete connection between the clinical event and the commercial account: the product used, the use reported and the sale recognized should describe the same transaction.

The purchase-to-claim path looks like this:

Does Medicare Cover Devices?

Medicare covers a device only if it fits a benefit category and meets the applicable coverage conditions. FDA marketing authorization alone is not enough. A billing code and Medicare coverage answer different questions. Payment adds another question: what amount goes to which provider?

Coverage concerns the item or service and the circumstances in which Medicare pays for it. The Medicare coverage law requires care for diagnosis or treatment to be reasonable and necessary. National coverage determinations and local contractor policies can set conditions that reach the hospital and the patient’s chart.

Coding describes what was provided. CPT describes procedures, and HCPCS Level II principally identifies products, supplies and services outside CPT. Inpatient diagnosis and procedure codes help determine the payment group for the hospital stay. A product’s code supplies information to that process. It does not settle the payment amount.

Payment assigns the amount under the system that applies to the setting. The same commercial product may enter a hospital bundle, a temporary additional payment or a physician-office practice-expense calculation.

For transcatheter aortic valve replacement, the national coverage determination requires participation in a prospective, national, audited registry that consecutively enrolls patients and accepts all manufactured devices. That is an operational requirement sitting upstream of the payment calculation.

Where the Procedure Happens Changes the Payment

The setting determines which Medicare payment system handles the facility’s costs and which handles the physician’s work. The implant invoice follows the purchase agreement. It does not set the Medicare rate.

Some devices instead belong to the separately billed durable medical equipment, prosthetics, orthotics and supplies system, outside a hospital service. That supplier payment route is distinct from an implant furnished as part of hospital care.

Inpatient Hospitals and MS-DRGs

The Inpatient Prospective Payment System pays hospitals at predetermined discharge rates based on Medicare Severity Diagnosis-Related Groups. The implant’s cost ordinarily sits within the payment for the stay.

CMS’s fiscal 2026 inpatient payment instructions explain that diagnosis codes, procedure codes and patient information determine the group.

CMS recalibrates the group weights using hospital charges and cost-to-charge ratios. The resulting payment is for the stay, rather than each implant invoice.

Device choice can nevertheless affect the group itself. In the fiscal 2026 MS-DRG titles, a custom-made anatomically designed interbody fusion device was an alternative to a major complication or comorbidity in the higher group for certain spinal fusions. Here, the selected product could change the payment for the whole stay. The money still traveled through the hospital’s group payment.

Hospital Outpatient Departments and APCs

The Outpatient Prospective Payment System pays according to the assigned ambulatory payment classification. Its packaging rule includes implantable and insertable devices, including replacement devices, among the costs built into the service payment.

An implant shown on a hospital claim but not separately reimbursed is therefore part of the ordinary payment structure. Applicable device codes and charges can appear alongside the procedure even when Medicare includes the device cost in the procedure rate. The visible line and the paid unit are different things.

Ambulatory Surgery Centers

Medicare packages implanted prosthetic devices and implanted durable medical equipment into an ambulatory surgery center’s payment for the covered procedure, except where a specific payment exception applies. Devices on pass-through status are an important exception.

A device-intensive procedure receives special rate treatment within the surgery-center system. The device portion uses the hospital outpatient amount, while the service portion uses the surgery-center rate. The adjustment recognizes the device’s share of the procedure cost. It remains a procedure payment.

Physicians in Facilities and Offices

The physician fee schedule distinguishes facility and nonfacility practice expense. In a physician’s office, the calculation includes direct costs for supplies, clinical staff and equipment. An implant can enter that calculation as a medical supply.

In a hospital or other facility, a separate payment system pays the facility’s direct costs. The physician’s professional rate reflects that division. Comparing the office rate with the facility physician rate alone leaves the facility payment out of the comparison.

A physician practice-expense device input is a building block used to calculate the service rate. A named implant and price in a CMS supply file do not constitute a separately payable Medicare device fee. The hospital’s invoice, the office supply input and the professional payment serve different purposes.

When Medicare Adds a Device Payment

New technology add-on payments and outpatient pass-through payments can add money beyond the ordinary bundle. Each has its own eligibility and calculation. The name of the device is only part of the payment question.

How Are NTAP Payments Calculated?

New technology add-on payments cover part of qualifying inpatient costs above the ordinary group payment, subject to a technology-specific maximum. The device calculation uses the lesser of 65% of the technology’s estimated cost and that percentage of the case’s cost above the group payment.

That device rate applies to discharges on or after October 1, 2019. It describes a capped additional payment, rather than an agreement to reimburse the hospital’s purchase price.

The traditional eligibility path tests newness, cost and substantial clinical improvement. An alternative path for qualifying FDA breakthrough devices uses breakthrough designation and marketing authorization in place of a separate substantial-clinical-improvement showing, while retaining the newness and cost requirements.

The temporary payment gives a qualifying technology a route into the inpatient system while the regular group weights catch up with its costs. For a hospital evaluating a manufacturer’s reimbursement projection, the approved technology, treatment date, case cost and published maximum belong together.

How Does Device Pass-Through Payment Work?

Outpatient device pass-through payment uses the hospital’s charge adjusted to cost, then subtracts the device portion already included in the procedure payment. That subtraction is the device offset. The formula is not simply the manufacturer’s invoice added to the hospital’s ordinary payment.

Pass-through status attaches to a category described by a code. A qualifying product matching that category can receive the treatment, including a competing manufacturer’s product. Categories last at least two years and no more than three before their costs move into ordinary packaging.

The category, its effective period and the associated procedure matter together. A reimbursement presentation that names only the product and the additional payment leaves out the offset and the category’s clock.

Why the Implant Price Is Not the Hospital Margin

Hospital acquisition cost is what the institution pays for the implant under its purchasing or consignment arrangement. The hospital’s charge is what appears in its billing system. Medicare payment follows the applicable payment rules. Hospital margin concerns the payment left after the costs of providing the care.

The device offset is another distinct amount: the portion of the procedure payment attributed to the device for the relevant calculation. It is not a vendor discount or a credit memo. In pass-through payment, it prevents the device amount already inside the procedure rate from being paid again.

This is why a comparison between an implant’s purchase price and the entire Medicare procedure payment cannot establish the hospital’s margin. The procedure payment also supports the other costs of delivering care. The charge shown for the implant does not tell you what Medicare paid.

The useful comparison follows the same care episode through both sides of the accounts: what the hospital acquired, any credit it received, what it charged, and what the payment system paid. The return of a defective device can change the purchasing side after the original implant has already been used.

Replacement Credits Have to Reach the Claim

A replacement device supplied free or with a qualifying manufacturer credit can reduce Medicare’s hospital payment. Packaging keeps the device inside the bundle, but the credit can change what Medicare owes for that bundle.

CMS’s June 2026 cardiac-device billing guidance addresses pacemakers, defibrillators and their electrical leads. It describes replacements for defects, recalls, battery depletion and mechanical complications, and requires hospitals to identify and track the replacement claims when manufacturer credits apply.

For specified inpatient groups, CMS reduces payment when an implanted replacement device comes without cost or with a credit equal to at least 50% of the replacement device’s cost. Outpatient cardiac-device credit policy also uses that threshold for qualifying partial credits, with the payment reduction capped at the applicable device offset.

The reporting machinery connects the vendor account to the Medicare claim. Value code FD communicates the credit or price reduction. The condition codes identify why the replacement occurred. A credit sitting in the manufacturer’s account and a claim showing the credit are different records of the same event.

The CMS guidance even addresses a no-cost device whose hospital billing system demands a charge. The line may carry a token charge. The claim can therefore show a device and a charge even though the hospital received it free.

For someone in supply chain or revenue cycle, a replacement credit not passed from supply chain to billing is a concrete payment question. The credit memo, replacement record and billed claim connect what the hospital saved to whether Medicare’s payment changed.

When Reimbursement Advice Changes the Hospital Bill

A manufacturer can influence the hospital’s claim through the reimbursement advice it gives its customers. The kyphoplasty cases show why the setting decision belongs beside the product sale.

Medtronic Spine, Kyphon’s corporate successor, agreed to a $75 million civil settlement in May 2008 over allegations that it encouraged unnecessary inpatient kyphoplasty admissions to increase hospital reimbursement. Kyphoplasty treats certain spinal fractures. The government’s allegation concerned counseling hospitals to use inpatient treatment when the procedure should often have been outpatient.

The disputed money came through the hospital’s claim. The manufacturer’s alleged contribution was the advice that helped produce it.

A whistleblower complaint concerning FoxHollow described the same commercial pressure in internal language:

The complaint alleged that the manufacturer’s sales organization treated the customer’s outpatient billing pattern as something to change. That puts the reimbursement message itself among the records worth examining.

A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting in 2020, explains why a False Claims Act case follows the request for government money and the statements that brought about payment. For a device insider, the connection is concrete: what did the sales presentation tell the hospital to bill, and what did the hospital bill?

Purchasing records establish the acquisition. Implant and operative records establish the product used. Coding instructions and reimbursement presentations show what the customer was told. Claims and payment records show where that advice reached Medicare.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know the Purchase and the Payment

If you know the implant price, the credit that stayed in purchasing or the reimbursement instructions customers received, speak with our whistleblower experts. We stay beside you through the case and bring in healthcare fraud whistleblower lawyers who understand hospital payment and manufacturer reimbursement practices, so your knowledge of the device business can build your strongest whistleblower case.